Bionyra Pharma
Developing next-generation biologics for severe immunological and inflammatory diseases
$165MSeries A
Role not disclosedSD
Sixty Degree Capital
Activity from announced rounds
Activity in this selectionnomura-real-estate-development-co-f095adde
- Rounds participated in
- 6
- Confirmed lead rounds
- — 6 roles undisclosed
- New companies
- 6 First participation on record · 0 follow-on
- Funding in participating rounds
- $698M 6 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
6 in this selectionEclypsium
Provides supply chain security for IT infrastructure
$25MSeries C+
Role not disclosedCrossbow Therapeutics
Develops a novel class of potent and precise antibody therapies to treat a broad range of cancers
$77MSeries B
Role not disclosedHawkEye 360
Detects, geolocates, and characterizes RF signals using a commercial satellite constellation
$23MSeries E
Role not disclosedKinaset Therapeutics
Develops inhaled therapies for severe respiratory diseases
$103MSeries B
Role not disclosedParabilis Medicines
Develops medicines targeting historically undruggable protein targets in cancer
$305MSeries F
Role not disclosed